Enliven Therapeutics Inc.

09/28/2024 | Press release | Distributed by Public on 09/28/2024 12:49

Enliven Therapeutics Announces Positive Data Update from Phase 1 Clinical Trial of ELVN-001 in Chronic Myeloid Leukemia